Assembly Biosciences, Inc. - stock earnings
ASMB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -14.4 million USD | ? USD |
| 2023Q2 | -16.9 million USD | ? USD |
| 2023Q1 | -18.3 million USD | ? USD |
| 2022Q4 | -21.6 million USD | ? USD |
| 2022Q3 | -22.9 million USD | ? USD |
| 2022Q2 | -24.3 million USD | ? USD |
| 2022Q1 | -23.0 million USD | ? USD |
| 2021Q4 | -60.3 million USD | ? USD |
| 2021Q3 | -18.8 million USD | 6.3 million USD |
| 2021Q2 | -23.6 million USD | ? USD |
| 2021Q1 | -27.2 million USD | ? USD |
| 2020Q4 | -39.4 million USD | 1.0 million USD |
| 2020Q3 | -3.3 million USD | 34.6 million USD |
| 2020Q2 | 7.3 million USD | 39.4 million USD |
| 2020Q1 | -26.7 million USD | 4.1 million USD |
| 2019Q4 | -27.1 million USD | 4.8 million USD |
| 2019Q3 | -25.0 million USD | 4.2 million USD |
| 2019Q2 | -18.5 million USD | 3.1 million USD |
| 2019Q1 | -27.1 million USD | 3.9 million USD |
| 2018Q4 | -26.2 million USD | 3.7 million USD |
| 2018Q3 | -21.5 million USD | 4.3 million USD |
| 2018Q2 | -26.8 million USD | 3.2 million USD |
| 2018Q1 | -16.2 million USD | 3.6 million USD |
| 2017Q4 | -3.0 million USD | 3.3 million USD |
| 2017Q3 | -12.3 million USD | 2.7 million USD |
| 2017Q2 | -13.6 million USD | 2.4 million USD |
| 2017Q1 | -13.9 million USD | 684369 USD |
| 2016Q4 | -11.5 million USD | ? USD |
| 2016Q3 | -11.6 million USD | ? USD |
| 2016Q2 | -10.2 million USD | ? USD |
| 2016Q1 | -11.0 million USD | ? USD |
| 2015Q4 | -7.7 million USD | ? USD |
| 2015Q3 | -6.6 million USD | ? USD |
| 2015Q2 | -6.9 million USD | ? USD |
| 2015Q1 | -7.1 million USD | ? USD |
| 2014Q4 | -6.2 million USD | ? USD |
| 2014Q3 | -11.0 million USD | ? USD |
| 2014Q2 | -2.5 million USD | ? USD |
| 2014Q1 | -4.1 million USD | ? USD |
| 2013Q4 | -6.0 million USD | ? USD |
| 2013Q3 | -4.9 million USD | ? USD |
| 2013Q2 | -4.8 million USD | ? USD |
| 2013Q1 | -3.7 million USD | ? USD |
| 2012Q4 | -3.8 million USD | ? USD |
| 2012Q3 | -5.4 million USD | ? USD |
| 2012Q2 | -7.5 million USD | ? USD |
| 2012Q1 | -8.2 million USD | ? USD |
| 2011Q4 | -18.9 million USD | ? USD |
| 2011Q3 | -5.8 million USD | ? USD |
| 2011Q2 | -7.0 million USD | ? USD |
| 2011Q1 | -9.4 million USD | -16.4 billion USD |
| 2010Q4 | -9.4 million USD | ? USD |
| 2010Q3 | -1.8 million USD | ? USD |
| 2010Q2 | -2.1 million USD | ? USD |
| 2010Q1 | -2.0 million USD | ? USD |
| 2009Q4 | -1.6 million USD | ? USD |
| 2009Q3 | -936822 USD | ? USD |
| 2009Q2 | -591306 USD | ? USD |
| 2009Q1 | -1.4 million USD | ? USD |
ASMB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -72.7 million USD | ? USD |
| 2022 | -92.1 million USD | ? USD |
| 2021 | -129.9 million USD | 6.3 million USD |
| 2020 | -59.5 million USD | 79.1 million USD |
| 2019 | -97.6 million USD | 16.0 million USD |
| 2018 | -90.8 million USD | 14.8 million USD |
| 2017 | -42.8 million USD | 9.0 million USD |
| 2016 | -44.3 million USD | ? USD |
| 2015 | -28.5 million USD | ? USD |
| 2014 | -23.8 million USD | ? USD |
| 2013 | -19.4 million USD | ? USD |
| 2012 | -24.8 million USD | ? USD |
| 2011 | -34.3 million USD | ? USD |
| 2010 | -15.3 million USD | ? USD |
| 2009 | -4.5 million USD | ? USD |
| 2008 | -8.8 million USD | ? USD |
ASMB
Price: $13.15
52 week price:
Payout Ratio Range:
Earnings Per Share: -13.38 USD
P/E Ratio: -0.70
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 311844
Ebitda: -12.4 millionMarket Capitalization: 80.3 million